Denmark· DK-28105848416
Empressin
A vasopressin (argipressin) product containing argipressin, registered in Denmark by Orpha Devel Handels- und Vertr.. The same ATC class is registered in 10 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Vasopressin (argipressin) is registered in 10 of 19 countries.
Countries holding a registration under ATC H01BA01 (vasopressin (argipressin)), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 6 of them publish a price we can compare per daily dose
Vasopressin (argipressin) · ATC H01BA01
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Argipressin
- Manufacturer
- Orpha Devel Handels- und Vertr.
- Country
- Denmark (DK)
- ATC code
- H01BA01
- ATC class
- Vasopressin (argipressin)
- Defined daily dose
- 40 E, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105848416
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
166 interactions on record for vasopressin (argipressin).
Graded by severity as the source publishes them — 39 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Vasopressin (argipressin) · interactions on record
166 records
- 39 severe
- 125 moderate
- 2 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- PapaverinC04AX38severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under H01BA01
Vasopressin (argipressin), as other registers publish it.
- PolandArgipressin FarmakFarmak International Sp. z o.o.
- CzechiaEMBESINOrpha-Devel Handels und Vertriebs GmbH, Purkersdorf
- CzechiaEMBESINOrpha-Devel Handels und Vertriebs GmbH, Purkersdorf
- CzechiaEMBESINOrpha-Devel Handels und Vertriebs GmbH, Purkersdorf
- IrelandEmbesin 20 IU/ml concentrate for solution for infusionOrpha-Devel Handels und Vertriebs GmbH
- PolandEmpesinOrpha-Devel Handels und Vertriebs GmbH
- DenmarkEmpressinOrifarm A/S
- FinlandEmpressinOrifarm Oy
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/12e9e422-a2ba-426f-8a49-6c17f0a9a92c GET /v1/drugs/12e9e422-a2ba-426f-8a49-6c17f0a9a92c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "koncentrat til infusionsvæske, opløsning",
"source": "dkma",
"strength": "40 IE/2 ml",
"auth_role": "CMS",
"dk_drugid": "28105848416",
"substance": "Argipressin",
"auth_procedure": "MRP",
"in_medicinpriser": true,
"registration_date_serial": "43294"
}See everything about vasopressin (argipressin).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.